| Annmarie Miranda, PA-C | |
|
9500 Euclid Ave, Cleveland, OH 44195-0001 | |
| (216) 444-6575 | |
| Not Available |
| Full Name | Annmarie Miranda |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 9500 Euclid Ave, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285207167 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50.006700RX (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic | Cleveland, OH | Hospital |
| Hillcrest Hospital | Mayfield heights, OH | Hospital |
| Akron General Medical Center | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
Glenmark Pharmaceuticals S.A, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India, announced today that it has entered into an agreement with Sanofi to grant Sanofi a license for the development and commercialization of GBR 500, a novel monoclonal antibody for the treatment of Crohn's Disease and other inflammatory conditions.
While the medical community continues to debate the benefits of CYP2D6 genetic testing for women on the breast cancer treatment tamoxifen, patients using the medication are anxious to have the tests. According to a new survey of more than 700 women with breast cancer currently taking tamoxifen, almost 80 percent of respondents would choose to have a genetic test that determines CYP2D6 genotype, yet only 14 percent of these women have been tested. CYP2D6 is an enzyme that influences how well the body processes tamoxifen into its more active form.
Dr. Keiji Fukuda an expert at the Centres for Disease Control and Prevention is warning that the incident of the particularly lethal variation of influenza in Southeast Asia is probably far greater than has been reported so far.
A forthcoming article to be published in the July 2006 issue of the American Journal of Kidney Diseases finds that physician decision-making for the delivery of epoetin therapy is primarily influenced by the type of ownership and financial incentives associated with dialysis centers.
Biogenic amines may be one of the factors responsible for symptoms such as headaches, gastro-intestinal disorders, shortness of breath, fall in blood pressure, and even unconsciousness and cardiac arrhythmia in severe cases. Histamine, one of the best known members of this group, can cause serious physical problems. Biogenic amines can be produced in the body by natural metabolic activities but are also ingested in larger quantities with food.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Annmarie Miranda, PA-C 9500 Euclid Ave # A50, Cleveland, OH 44195-4419 Ph: (216) 444-6575 | Annmarie Miranda, PA-C 9500 Euclid Ave, Cleveland, OH 44195-0001 Ph: (216) 444-6575 |
News Archive
Glenmark Pharmaceuticals S.A, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India, announced today that it has entered into an agreement with Sanofi to grant Sanofi a license for the development and commercialization of GBR 500, a novel monoclonal antibody for the treatment of Crohn's Disease and other inflammatory conditions.
While the medical community continues to debate the benefits of CYP2D6 genetic testing for women on the breast cancer treatment tamoxifen, patients using the medication are anxious to have the tests. According to a new survey of more than 700 women with breast cancer currently taking tamoxifen, almost 80 percent of respondents would choose to have a genetic test that determines CYP2D6 genotype, yet only 14 percent of these women have been tested. CYP2D6 is an enzyme that influences how well the body processes tamoxifen into its more active form.
Dr. Keiji Fukuda an expert at the Centres for Disease Control and Prevention is warning that the incident of the particularly lethal variation of influenza in Southeast Asia is probably far greater than has been reported so far.
A forthcoming article to be published in the July 2006 issue of the American Journal of Kidney Diseases finds that physician decision-making for the delivery of epoetin therapy is primarily influenced by the type of ownership and financial incentives associated with dialysis centers.
Biogenic amines may be one of the factors responsible for symptoms such as headaches, gastro-intestinal disorders, shortness of breath, fall in blood pressure, and even unconsciousness and cardiac arrhythmia in severe cases. Histamine, one of the best known members of this group, can cause serious physical problems. Biogenic amines can be produced in the body by natural metabolic activities but are also ingested in larger quantities with food.
› Verified 6 days ago
Ms. Janice Louise Todd, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1730 W 25th St, Cleveland, OH 44113 Phone: 216-696-4300 Fax: 216-696-7269 | |
Kara Hoye, Physician Assistant Medicare: Medicare Enrolled Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-445-4500 | |
Michelle Simmons, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-2200 | |
Mr. Dominic Peterre, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, H 606, Cleveland, OH 44109 Phone: 216-778-3868 | |
Lynn Pagliaccio, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195 Phone: 216-445-4525 | |
James D Cribbins, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 | |
Todd A Storch, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2351 E 22nd St, Cleveland, OH 44115 Phone: 216-861-6200 |